Form 4 for ABT Abbott Laboratories
Accepted 2022-06-14 00:00:00 ET · period of report 2022-06-10 · accession 0001415889-22-006538 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-06-14 | 2022-06-10 | ABT | Earnhardt Lisa D | EVP | F - Tax | $112.71 | -22.5K | 87.7K | -20% | -$2.53M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2022-06-10 | F | D | 19,592 | $112.71 | 68,156 | D | — | — | |
| 2 | Common | Common shares without par value | 2022-06-10 | F | D | 2,882 | $112.71 | 87,748 | D | — | — |